Barrier function and microbiotic dysbiosis in atopic dermatitis
Sophie Seite,1 Thomas Bieber2 1La Roche-Posay Dermatological Laboratories, Asnières, France; 2Department of Dermatology and Allergy, Friedrich-Wilhelms-University, Bonn, GermanyAbstract: Atopic dermatitis (AD) or atopic eczema is the common inflammatory skin disorder, the prevalence of wh...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-09-01
|
| Series: | Clinical, Cosmetic and Investigational Dermatology |
| Online Access: | https://www.dovepress.com/barrier-function-and-microbiotic-dysbiosis-in-atopic-dermatitis-peer-reviewed-article-CCID |
| _version_ | 1828375488462061568 |
|---|---|
| author | Seite S Bieber T |
| author_facet | Seite S Bieber T |
| author_sort | Seite S |
| collection | DOAJ |
| description | Sophie Seite,1 Thomas Bieber2 1La Roche-Posay Dermatological Laboratories, Asnières, France; 2Department of Dermatology and Allergy, Friedrich-Wilhelms-University, Bonn, GermanyAbstract: Atopic dermatitis (AD) or atopic eczema is the common inflammatory skin disorder, the prevalence of which has considerably increased during the last 30 years. It affects 15%–30% of children and 2%–10% of adults. AD characteristically alternates between periods of exacerbation or flares and periods of remission, which may be therapeutically induced or spontaneous. Current knowledge about AD includes abnormalities of the skin barrier (physical and chemical), the immune barrier, and more recently, the microbial barrier or microbiota. There is growing evidence for a tight relationship between them. To obtain satisfactory control of this condition, the clinical strategy to manage AD involves prescribing both anti-inflammatory medications and dermocosmetic products. The role of the physician is therefore to advise the patient with regard to hygiene measures aimed to help to improve these three barriers or to prevent any further deterioration. Keywords: atopic dermatitis, eczema, skin barrier, microbiome, immunity, dermocosmetic |
| first_indexed | 2024-04-14T07:47:15Z |
| format | Article |
| id | doaj.art-88341ece296449c993d53a59e2606894 |
| institution | Directory Open Access Journal |
| issn | 1178-7015 |
| language | English |
| last_indexed | 2024-04-14T07:47:15Z |
| publishDate | 2015-09-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Clinical, Cosmetic and Investigational Dermatology |
| spelling | doaj.art-88341ece296449c993d53a59e26068942022-12-22T02:05:18ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152015-09-012015default47948323665Barrier function and microbiotic dysbiosis in atopic dermatitisSeite SBieber TSophie Seite,1 Thomas Bieber2 1La Roche-Posay Dermatological Laboratories, Asnières, France; 2Department of Dermatology and Allergy, Friedrich-Wilhelms-University, Bonn, GermanyAbstract: Atopic dermatitis (AD) or atopic eczema is the common inflammatory skin disorder, the prevalence of which has considerably increased during the last 30 years. It affects 15%–30% of children and 2%–10% of adults. AD characteristically alternates between periods of exacerbation or flares and periods of remission, which may be therapeutically induced or spontaneous. Current knowledge about AD includes abnormalities of the skin barrier (physical and chemical), the immune barrier, and more recently, the microbial barrier or microbiota. There is growing evidence for a tight relationship between them. To obtain satisfactory control of this condition, the clinical strategy to manage AD involves prescribing both anti-inflammatory medications and dermocosmetic products. The role of the physician is therefore to advise the patient with regard to hygiene measures aimed to help to improve these three barriers or to prevent any further deterioration. Keywords: atopic dermatitis, eczema, skin barrier, microbiome, immunity, dermocosmetichttps://www.dovepress.com/barrier-function-and-microbiotic-dysbiosis-in-atopic-dermatitis-peer-reviewed-article-CCID |
| spellingShingle | Seite S Bieber T Barrier function and microbiotic dysbiosis in atopic dermatitis Clinical, Cosmetic and Investigational Dermatology |
| title | Barrier function and microbiotic dysbiosis in atopic dermatitis |
| title_full | Barrier function and microbiotic dysbiosis in atopic dermatitis |
| title_fullStr | Barrier function and microbiotic dysbiosis in atopic dermatitis |
| title_full_unstemmed | Barrier function and microbiotic dysbiosis in atopic dermatitis |
| title_short | Barrier function and microbiotic dysbiosis in atopic dermatitis |
| title_sort | barrier function and microbiotic dysbiosis in atopic dermatitis |
| url | https://www.dovepress.com/barrier-function-and-microbiotic-dysbiosis-in-atopic-dermatitis-peer-reviewed-article-CCID |
| work_keys_str_mv | AT seites barrierfunctionandmicrobioticdysbiosisinatopicdermatitis AT biebert barrierfunctionandmicrobioticdysbiosisinatopicdermatitis |